Anne Wojcicki
23andMe Raises $115 Million as It Ramps Up Genetic Testing Internationally
The startup that hit a roadblock with the FDA two years ago is now the leading personal genetics company.
Advertisement
Advertisement
Advertisement
The startup that hit a roadblock with the FDA two years ago is now the leading personal genetics company.